摘要
目的研究不同治疗方式应用于急性脑出血中的疗效。方法回顾性分析我院收治的94例急性脑出血患者的临床资料,按照治疗方法将患者分为对照组及研究组,各47例。两组急性脑出血患者均行常规治疗,在此基础上对照组行依达拉奉治疗,研究组行醒脑静与依达拉奉联合治疗。比较两组患者治疗前、后神经功能缺损评分、血肿量、GCS评分与治疗总有效率。结果研究组治疗后总有效率(97.88%)高于对照组(76.60%)(P<0.05);治疗后,两组患者的神经功能缺损评分、血肿量及GCS评分均显著改善,且研究组优于对照组(P<0.05)。结论醒脑静与依达拉奉联合治疗急性脑出血具有显著效果,可改善神经功能,降低血肿量,值得推广应用。
Objective To study the effect of different methods in the treatment of acute cerebral hemorrhage. Methods The clinical data of 94 patients with acute cerebral hemorrhage admitted in our hospital were retrospectively analyzed. The patients were divided into control group and study group according to the treatment method, with 47 cases in each group.The patients of the two groups with acute cerebral hemorrhage underwent routine treatment, based on the routine treatment,the control group was treated with edaravone, and the study group was treated with edaravone and Xingnaojing injection.The neurological deficit scores, hematoma volume, GCS scores before and after treatment and total effective rates in the two groups were compared. Results The total effective rate of the study group after treatment(97.88%) was higher than that of the control group(76.60%)(P〈0.05). After treatment, the neurological deficit scores, hematoma volume and GCS scores of both groups significantly improved, and those of the study group was better than the control group(P〈0.05). Conclusion Edaravone and Xingnaojing injection in the treatment of acute cerebral hemorrhage has significant effect, it can improve nerve function, reduce the amount of hematoma, which is worthy of promotion and application.
出处
《临床医学研究与实践》
2018年第3期32-33,共2页
Clinical Research and Practice
关键词
依达拉奉
醒脑静
急性脑出血
edaravone
Xingnaojing injection
acute cerebral hemorrhage